Millie
your market intelligence analyst
Search Results
302 results
Your search is now limited to «AbbVie» expert search.
SmartMoney 07/22/2019 09:32
AbbVie AbbVie is scheduled to report second-quarter earnings on Friday.
More from SmartMoney:
PR Newswire 07/19/2019 07:19
AbbVie's pipeline JAK1 selective inhibitor, upadacitinib, is expected to become available for the treatment of RA in the next few months, and rheumatologists' reported familiarity with the late-stage agent has increased two-fold in the ...
More from PR Newswire:
PharmiWeb.com 07/18/2019 06:00
According to a newly published report by market.us, “Worldwide Sodium Valproate Market: Information About Key Drivers, Restraints, And Opportunities 2019-2028“. The prime objective of the report is to deliver a Ten-year (2019-2028) market forecast. The latest study focusing on sodium valproate market with topmost companies, to determine, define and analyses the sales size, value, market share, market competition landscape, and recent development. It helps to decide a corporate, product, marketin…
More from PharmiWeb.com:
Zacks.com 07/17/2019 09:00
AbbVie ( ABBV - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy.
More from Zacks.com:
STING pathway signaling plays an important role in the generation of an immune response directed at tumors, and enhancing STING signaling has shown promise in a variety of. .
More from Pharmaceutical Business Review:
Market Exclusive 07/16/2019 18:09
The factors described in the context of such forward-looking statements in this communication could cause AbbVie’s plans with respect to Allergan, Allergan’s or AbbVie’s actual results, performance or achievements, industry results and developments to differ materially from those expressed in or implied by such forward-looking statements.
More from Market Exclusive:
(MENAFN - Baystreet.ca) Nearly a month after announcing the company's intentions to acquire rival drugmaker Allergan Plc (NYSE:AGN) for a whopping $63 billion U.S., investors in wh...
More from Middle East North Africa Financial Network (MENAFN):
FiercePharmaManufacturing 07/15/2019 10:03
RELATED: AbbVie shakes up psoriasis field with blockbuster-to-be newcomer Skyrizi Alongside a price tag that AbbVie said beats out any other biologic for moderate to severe plaque psoriasis, Skyrizi also benefits from a less onerous dosing regimen with maintenance doses delivered every 12 weeks rather than the industry standard four weeks ...
More from FiercePharmaManufacturing:
ENDPOINTS 07/15/2019 08:58
AbbVie isn’t letting its $63 billion buyout of Allergan stop its M&A/deals team from continuing their work.
More from ENDPOINTS:
Benzinga 07/15/2019 08:53
AbbVie's vision in oncology is to advance breakthrough areas of science leading to a strong pipeline of innovative cancer therapies," said Steve Davidsen, AbbVie's vice president of oncology discovery.
More from Benzinga:
Seeking Alpha 07/13/2019 05:43
Arbitrage on the ABBV-AGN merger remains high. You can secure a $52.60 cost basis on ABBV shares by buying AGN. Put options can mitigate the risk of merger fail.
More from Seeking Alpha:
Investor's Business Daily 07/09/2019 08:00
AbbVie Attempts To Buy Allergan AbbVie is planning to buy Botox-maker Allergan for $63 billion.
More from Investor's Business Daily:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications